期刊文献+

间质性肺疾病与肿瘤标记物及血清因子的关系研究进展

Research Progress on the Relationship between Interstitial Lung Disease and Tumor Markers and Serum Factors
下载PDF
导出
摘要 近年来,间质性肺疾病引起了人们越来越多的重视,学者对其的研究也越来越多。众多学者尤其是国外学者研究发现:① 间质性肺疾病患者血清中部分肿瘤标记物,如CEA、CA19-9、SCC等会有一定程度的升高,但需警惕存在继发或者合并肿瘤的情况;② 不同原因所致的间质性肺疾病,血清肿瘤标记物升高的水平不同;③ 肿瘤标记物升高的水平可能与疾病的严重程度、治疗效果及转归有关;④ 除肿瘤标记物外,间质性肺疾病患者血清因子也有一定程度的升高,部分血清因子具有预测结局的作用。 In recent years, interstitial lung disease has attracted more and more attention, and more and more scholars have studied it. Many scholars, especially foreign scholars, have found that: ① Some tumor markers in the serum of patients with interstitial lung disease, such as CEA, CA19-9, SCC, etc., will increase to a certain extent, but it is necessary to be alert for the presence of secondary or combined tumors Situation;② Interstitial lung disease caused by different reasons, the level of elevated serum tumor markers is different;③ The increased level of tumor markers may be related to the severity of the disease, treatment effect and outcome;④ In addition to tumor markers, the serum factor of patients with interstitial lung disease also increased to a certain extent, and some serum factors have the effect of predicting the outcome.
作者 段兴秋
出处 《临床医学进展》 2020年第6期914-919,共6页 Advances in Clinical Medicine
关键词 间质性肺疾病 肿瘤标记物 血清因子 Interstitial Lung Disease Tumor Marker Serum Factor
  • 相关文献

参考文献10

二级参考文献75

  • 1Calabrese F, Lunardi F, Giacometti C. Over expession of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis:clinico pathological correlations[ J]. Thorax, 2008 ;63:795 - 802.
  • 2Yamamoto M, Igawa K, Tatsukawa T, et al. A case of idiopathic interstitial Pneumonia with marked increase of CA19 -9 in serum and BALF[ J]. Nihon Kokyuki Gakkai Zasshi, 1998 ; 36:273 - 277.
  • 3Totani Y, Saito Y, Miyachi H, et al. Clinical characterization of CA19 -9 in patients with interstitial pneumonia showing pathological nonspecific interstitial Pneumonia pattern[ J]. Nihon Kokyuki Gakkai Zasshi,2005 ; 43:77 -83.
  • 4Molina R, Auge JM, Escudero JM, et al. Mucins CA 12-5, CA 19 -9, CA 153 and TAG- 723 as tumor markers in patients with lung cancer: comparison with CYFRA 21 - 1, CEA, SCC and NSE [ J ]. Tumor Biol, 2008 ; 29:371 - 380.
  • 5Kunisawa A,Kawanishi Y,Tago H,et al.Direct demonstration of the productive capability of cytokines at the single cell level in lung sarcoidosis using multicolor cytometry.Respiration,2002,69(2):155-164.
  • 6Antoniou KM,Ferdoutsis E,Bouros D.Interferons and their application in the diseases of the lung.Chest,2003,123(1):209-216.
  • 7Meloni F,Caporali R,Marone-Bianco A,et al.BAL cytokine profile in different interstitial lung diseases:a focus on systemic sclerosis.Sarcoidosis Vasc Diffuse Lung Dis,2004,21(2):111-118.
  • 8Segel MJ,Izbicki G,Cohen PY,et al.Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.Am J Physiol Lung Cell Mol Physiol,2003,285(6):L1255-L1262.
  • 9Aggarwal AN,Behera D.Interferon-gamma 1b:impact of new indications (idiopathic pulmonary fibrosis).Expert Opin Pharmacother,2000,1(7):1423-1427.
  • 10Ziesche R,Hofbauer E,Wittmann K,et al.A preliminary study of long-term treatment with interferon gamma-1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis.N Engl J Med,1999,341(17):1264-1269.

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部